Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.

RPEP-145702025Zhang, Yuze; Dong, Qiuting; Bian, Xiaohui; Qiao, Zheng; Cui, Chuanjue; Yang, Ning; Liu, Jincan; Fu, Rui; Zhang, Jun; Jia, Lei; Wu, Chao; Guo, Jincheng; Lin, Wenhua; Wang, Jingping; Fan, Jiamao; Li, Yang; Liu, Fan; Yang, Bin; Jia, Xinwei; Gao, Chuanyu; Bai, Ming; He, Yi; Han, Chengquan; Yin, Dong; Dou, Kefei

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.

Cardiovascular research, 121(17), 2747-2758

View on PubMed ↗Publisher’s paper ↗

Citation

Zhang, Yuze; Dong, Qiuting; Bian, Xiaohui; Qiao, Zheng; Cui, Chuanjue; Yang, Ning; Liu, Jincan; Fu, Rui; Zhang, Jun; Jia, Lei; Wu, Chao; Guo, Jincheng; Lin, Wenhua; Wang, Jingping; Fan, Jiamao; Li, Yang; Liu, Fan; Yang, Bin; Jia, Xinwei; Gao, Chuanyu; Bai, Ming; He, Yi; Han, Chengquan; Yin, Dong; Dou, Kefei. (2025). Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.. Cardiovascular research, 121(17), 2747-2758. https://doi.org/10.1093/cvr/cvaf223